Transcutaneous Bilirubinometry for the Screening of Neonatal Hyperbilirubinemia

Transcutaneous Bilirubinometry for the Screening of Hyperbilirubinemia in Neonates ≥35 Weeks’ Gestation

This report was prepared for Alberta Health Services (AHS) and focuses on the published evidence about the safety, test accuracy, and clinical impact of the use of transcutaneous bilirubin (TcB) test for the screening of significant hyperbilirubinemia in term or late pre-term neonates. This report also provides information regarding the current practices with TcB/total serum bilirubin (TSB) tests in AHS zones, and a brief review of economic literature regarding the cost implications and potential cost-effectiveness of TcB and/or TSB testing.

Section Authors:

• Section One – Background and Project Context: Ken Bond, Bing Guo
• Section Two – Technology Effects and Effectiveness: Bing Guo, Christa Harstall
• Section Three – Economic Analysis: Anderson Chuck, Charles Yan
• Information Specialist: Liz Dennett